Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in Inflammatory Bowel Disease (IBD) patients who meet the guidelines' criteria

American Journal of Gastroenterology

Volumn 101, Issue 7, 2006, Pages 1546-1550

  Kornbluth, Asher ^a   Hayes, Michael ^a   Feldman, Sari ^a   Hunt, Michele ^a   Fried Boxt, Elliot ^a   Lichtiger, Simon ^a   Legnani, Peter ^a   George, James ^a   Young, Jonathan ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; RISEDRONIC ACID; STEROID; VITAMIN D;

ADULT; ANAMNESIS; ARTICLE; BODY MASS; BONE DENSITY; CALCIUM INTAKE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FRACTURE; GENDER; HIP; HUMAN; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; POSTMENOPAUSE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

ADULT; BONE DENSITY; CHI-SQUARE DISTRIBUTION; DENSITOMETRY, X-RAY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MASS SCREENING; OSTEOPOROSIS; PRACTICE GUIDELINES; RISK FACTORS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33745567445     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00571.x     Document Type: Article

References (20)

1. Bernstein CN, Leslie WD, Leboff M. AGA technical review: Osteoporosis in gastrointestinal disease. Gastroenterology 2003;124:795-81.
2. : American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal disease. Gastroenterology 2003;124:791-4.
3. Bernstein CN, Leslie WD. Therapy insight: Osteoporosis in inflammatory bowel disease-advances and retreats. Nat Clin Pract Gastroenterol Hepatol 2005;2:232-9.
4. Stockbrugger RW, Schoon EJ, Collani S, et al. Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 2002;16:1519-27.
5. Raisz LG. Screening for osteoporosis. N Engl J Med 2005;353;164-71.
6. Bernstein CN, Katz S. Guidelines for osteoporosis and inflammatory bowel disease. A guide to diagnosis and management for the gastroenterologist (monograph). The American College of Gastroenterology, 2003.
7. Cummings SR. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-73.
8. Cohen S, Levy RM, Keller M, et al. Risedronate therapy prevents corticosteroid-induced bone loss. Arthritis Rheum 1999;42:2309-18.
9. American College of Rheumatology Ad Hoc Committee on Glucocorticoid Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 2001;44:1496-03.
10. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fractures among patients with IBD: A population-based study. Ann Intern Med 2000;133:795-9.
11. Klaus J, Armbrecht CN, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002;51:654-8.
12. Dinca M, Fries W, Luisetto G, et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999;94:1292-7.
13. Jahnsen J, Falch JA, Aadland E, et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study. Gut 1997;40:313-9.
14. Bernstein CN, Seeger LL, Sayre JW, et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250-6.
15. Siffledeen JS, Fedorak RN, Siminoski K, et al. Bones and Crohn's; risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 2004;10:220-8.
16. Siffledeen JS, Fedorak RN, Siminoski K, et al. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone density in Crohn's disease. Clin Gastroenterol Hepatol 2005;3:122-32.
17. Bernstein CN. Limiting fracture risk in Crohn's disease: Is there anything? Clin Gastroenterol Hepatol 2005;3:110-2.
18. Kane SV. Guidelines do help change behavior in the management of osteoporosis by gastroenterologists. Am J Gastroenterol 2003;98:A660.
19. Reddy S, Friedman S, Telford J. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 2005;110:1357-61.
20. Personal communication, Charles Bernstein, December 3, 2005.